145 related articles for article (PubMed ID: 12843739)
1. HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.
Schüpbach J; Böni J; Bisset LR; Tomasik Z; Fischer M; Günthard HF; Ledergerber B; Opravil M;
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):292-9. PubMed ID: 12843739
[TBL] [Abstract][Full Text] [Related]
2. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.
Böni J; Opravil M; Tomasik Z; Rothen M; Bisset L; Grob PJ; Lüthy R; Schüpbach J
AIDS; 1997 May; 11(6):F47-52. PubMed ID: 9143600
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss.
Schüpbach J; Günthard H; Joos B; Fischer M; Böni J; Tomasik Z; Yerly S; Perrin L; Battegay M; Furrer H; Vernazza P; Bernasconi E; Hirschel B;
J Acquir Immune Defic Syndr; 2005 Nov; 40(3):250-6. PubMed ID: 16249697
[TBL] [Abstract][Full Text] [Related]
4. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
Schüpbach J
AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
[TBL] [Abstract][Full Text] [Related]
5. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
Sterling TR; Hoover DR; Astemborski J; Vlahov D; Bartlett JG; Schupbach J
J Infect Dis; 2002 Oct; 186(8):1181-5. PubMed ID: 12355373
[TBL] [Abstract][Full Text] [Related]
6. The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.
Schapiro JM; Winters MA; Stewart F; Efron B; Norris J; Kozal MJ; Merigan TC
Ann Intern Med; 1996 Jun; 124(12):1039-50. PubMed ID: 8633817
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA.
Schüpbach J; Böni J; Flepp M; Tomasik Z; Joller H; Opravil M
J Med Virol; 2001 Oct; 65(2):225-32. PubMed ID: 11536227
[TBL] [Abstract][Full Text] [Related]
8. A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.
García F; Romeu J; Grau I; Sambeat MA; Dalmau D; Knobel H; Gomez-Sirvent JL; Arrizabalaga J; Cruceta A; Clotet BG; Podzamczer D; Pumarola T; Gallart T; O'Brien WA; Miró JM; Gatell JM
AIDS; 1999 Dec; 13(17):2377-88. PubMed ID: 10597779
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of p24-based antiretroviral treatment monitoring in pediatric HIV-1 infection: prediction of the CD4+ T-cell changes between consecutive visits.
Brinkhof MW; Böni J; Steiner F; Tomasik Z; Nadal D; Schüpbach J
J Acquir Immune Defic Syndr; 2006 Apr; 41(5):557-62. PubMed ID: 16652029
[TBL] [Abstract][Full Text] [Related]
10. Changes in immunoglobulin isotypes and immunoglobulin G (IgG) subclasses during highly active antiretroviral therapy: anti-p24 IgG1 closely parallels the biphasic decline in plasma viremia.
Voltersvik P; Albrektsen G; Ulvestad E; Dyrhol-Riise AM; Sørensen B; Asjö B
J Acquir Immune Defic Syndr; 2003 Dec; 34(4):358-67. PubMed ID: 14615653
[TBL] [Abstract][Full Text] [Related]
11. Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.
Prado JG; Shintani A; Bofill M; Clotet B; Ruiz L; Martinez-Picado J
J Clin Microbiol; 2004 Apr; 42(4):1620-5. PubMed ID: 15071015
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
[TBL] [Abstract][Full Text] [Related]
13. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.
Schüpbach J; Tomasik Z; Knuchel M; Opravil M; Günthard HF; Nadal D; Böni J; ;
J Med Virol; 2006 Aug; 78(8):1003-10. PubMed ID: 16789014
[TBL] [Abstract][Full Text] [Related]
14. Viral RNA and p24 antigen as markers of HIV disease and antiretroviral treatment success.
Schüpbach J
Int Arch Allergy Immunol; 2003 Nov; 132(3):196-209. PubMed ID: 14646380
[TBL] [Abstract][Full Text] [Related]
15. Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.
Kappes JC; Saag MS; Shaw GM; Hahn BH; Chopra P; Chen S; Emini EA; McFarland R; Yang LC; Piatak M
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):139-49. PubMed ID: 7552477
[TBL] [Abstract][Full Text] [Related]
16. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.
Orenstein JM; Bhat N; Yoder C; Fox C; Polis MA; Metcalf JA; Kovacs JA; Falloon J; Walker RE; Masur H; Lane HC; Davey RT
AIDS; 2000 Aug; 14(12):1709-15. PubMed ID: 10985306
[TBL] [Abstract][Full Text] [Related]
17. Quantitative molecular monitoring of HIV-1 RNA during antiretroviral therapy.
Lafeuillade A; Poggi C; Pellegrino P; Profizi N
Infection; 1996; 24(6):412-8. PubMed ID: 9007587
[TBL] [Abstract][Full Text] [Related]
18. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
Molina JM; Ferchal F; Chevret S; Barateau V; Poirot C; Morinet F; Modai J
AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.
de Mendoza C; Lu W; Machuca A; Sainz M; Castilla J; Soriano V
J Med Virol; 2001 Jul; 64(3):217-22. PubMed ID: 11424107
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of cimetidine on lymphocyte subsets in patients infected with human immunodeficiency virus type 1.
Cohen CJ; Hellinger JA; Day J; Salitsky N; Shevitz A; Zackin R; DeGruttola V
Clin Infect Dis; 1996 Nov; 23(5):1049-54. PubMed ID: 8922801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
